3.05
price down icon2.24%   -0.07
after-market Handel nachbörslich: 3.15 0.10 +3.28%
loading

Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten

pulisher
07:11 AM

Why analysts upgrade NRx Pharmaceuticals Inc. Equity Warrant stockPortfolio Update Summary & Real-Time Volume Analysis - newser.com

07:11 AM
pulisher
06:59 AM

Visual trend scoring systems applied to NRx Pharmaceuticals Inc.Quarterly Market Review & Real-Time Sentiment Analysis - newser.com

06:59 AM
pulisher
04:22 AM

What earnings revisions data tells us about NRx Pharmaceuticals Inc. Equity WarrantJuly 2025 Setups & AI Enhanced Trading Signals - newser.com

04:22 AM
pulisher
04:02 AM

Analyzing drawdowns of NRx Pharmaceuticals Inc. Equity Warrant with statistical tools2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - newser.com

04:02 AM
pulisher
Oct 13, 2025

Technical signs of recovery in NRx Pharmaceuticals Inc.2025 Major Catalysts & Smart Money Movement Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Will a bounce in NRx Pharmaceuticals Inc. Equity Warrant offer an exitWeekly Market Report & Safe Entry Point Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Will NRx Pharmaceuticals Inc. Equity Warrant stock recover faster than marketWeekly Trading Summary & Safe Entry Momentum Stock Tips - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Will NRx Pharmaceuticals Inc. Equity Warrant stock go up soon2025 Analyst Calls & Weekly High Momentum Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Pattern recognition hints at NRx Pharmaceuticals Inc. upsidePortfolio Value Report & Expert Approved Momentum Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What does recent volatility data suggest for NRx Pharmaceuticals Inc. Equity WarrantGap Down & Weekly Return Optimization Plans - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine - Amarillo Globe-News

Oct 13, 2025
pulisher
Oct 13, 2025

Live market analysis of NRx Pharmaceuticals Inc. Equity WarrantTrade Risk Report & Daily Price Action Insights - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

New to The Street Show #682 Premieres on Bloomberg Tonight Featuring Industry Leaders: DataVault, PetVivo, Health In Tech, FLOKI, and NRx Pharma Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustai - Corpus Christi Caller-Times

Oct 13, 2025
pulisher
Oct 13, 2025

Will NRx Pharmaceuticals Inc. stock gain from government policiesJuly 2025 PreEarnings & Growth Focused Entry Point Reports - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group - Columbia Daily Tribune

Oct 12, 2025
pulisher
Oct 12, 2025

Combining machine learning predictions for NRx Pharmaceuticals Inc.2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - MSN

Oct 11, 2025
pulisher
Oct 10, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) Strengthens Pipeline with Dual Pathways for Ketamine-Based Therapies - The Globe and Mail

Oct 10, 2025
pulisher
Oct 10, 2025

Will NRx Pharmaceuticals Inc. Equity Warrant outperform the marketOptions Play & Scalable Portfolio Growth Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

NRx Pharmaceuticals Inc. stock trend forecastJuly 2025 Volume & Smart Allocation Stock Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Why NRx Pharmaceuticals Inc. Equity Warrant stock could outperform in 20252025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Earnings visualization tools for NRx Pharmaceuticals Inc. Equity WarrantJuly 2025 Sentiment & Daily Volume Surge Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for NRx Pharmaceuticals (NASDAQ:NRXP) - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Why NRx Pharmaceuticals Inc. Equity Warrant stock is seen as undervaluedJuly 2025 Action & Risk Controlled Stock Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Applying Elliott Wave Theory to NRx Pharmaceuticals Inc. Equity WarrantMarket Rally & AI Driven Price Predictions - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is NRx Pharmaceuticals Inc. Equity Warrant forming a reversal pattern2025 Dividend Review & Safe Capital Investment Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

NRx Pharmaceuticals (NRXP) Strengthens Pipeline With Dual Pathways for Ketamine-Based Therapies - NewMediaWire

Oct 09, 2025
pulisher
Oct 09, 2025

Is NRx Pharmaceuticals Inc. Equity Warrant stock bottoming outOptions Play & Expert-Curated Trade Recommendations - newser.com

Oct 09, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):